Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones

Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones

US Patent 10195161 · Granted Feb 5, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Redox-active therapeutics for treatment of mitochondrial diseases and other cond2021
Treatment of pervasive developmental disorders with redox-active therapeutics2020
Treatment of pervasive developmental disorders with redox-active therapeutics2018
Treatment of oxidative stress disorders including contrast nephropathy, radiatio2018
Side-chain variants of redox-active therapeutics for treatment of mitochondrial 2018
Redox-active therapeutics for treatment of mitochondrial diseases and other cond2016
Treatment of pervasive developmental disorders with redox-active therapeutics2016
Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with2016
Side-chain variants of redox-active therapeutics for treatment of mitochondrial 2016
Treatment of pervasive developmental disorders with redox-active therapeutics2015
Treatment of pervasive developmental disorders with redox-active therapeutics2014
Treatment of pervasive developmental disorders with redox-active therapeutics2012